Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.46 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | HBB | P68871 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23607561 | 0.98 | TSHR (0.55) | TSHRTHRBPOLBAPEX1HTT | |
| Lithium Ion SCHEMBL16628565 | 0.96 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| Potassium Ion SCHEMBL379532 | 0.96 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16628435 | 0.96 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16628478 | 0.96 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16628613 | 0.96 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL8746515 | 0.95 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL28732492 | 0.94 | TSHR (0.51) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL18140257 | 0.93 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL29217626 | 0.93 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2023-03-30 | — | — | US | claimed |
| CN-115117442-A | Single-ion gel polymer electrolyte, preparation and application thereof | 华中科技大学 | 2022-09-27 | — | — | CN | claimed |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2022-06-09 | — | — | US | claimed |
| EP-3938359-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2022-01-19 | — | — | EP | claimed |
| WO-2020186077-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2020-09-17 | — | — | WO | claimed |
| US-9958797-B1 | Toner process comprising synthesizing amphiphilic block copolymers via emulsion polymerization | XEROX CORPORATION (US) | 2018-05-01 | — | — | US | claimed |
| EP-2705390-B1 | MEDICAL DEVICES HAVING HOMOGENEOUS CHARGE DENSITY AND METHODS FOR MAKING SAME | JOHNSON & JOHNSON VISION CARE (US) | 2016-07-20 | — | — | EP | claimed |
| EP-1521846-B1 | SERRS REACTIVE PARTICLES | UNIV STRATHCLYDE (GB) | 2013-03-06 | — | — | EP | claimed |
| US-20120125346-A1 | ENDOTRACHEAL CUFF AND TECHNIQUE FOR USING THE SAME | NELLCOR PURITAN BENNETT LLC (US) | 2012-05-24 | — | — | US | claimed |
| JP-4754213-B2 | — | — | 2011-08-24 | — | — | JP | claimed |
| US-20050130163-A1 | Serrs reactive particles | STRATHCLYDE, UNIVERSITY OF (GB) | 2005-06-16 | — | — | US | claimed |
| EP-1521846-A2 | SERRS REACTIVE PARTICLES | UNIVERSITY OF STRATHCLYDE (GB) | 2005-04-13 | — | — | EP | claimed |
| EP-1509302-A1 | SOLID MYCOCTOXIN CARRIERS | Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung (AT) | 2005-03-02 | — | — | EP | claimed |
| WO-2004007767-A2 | SERRS REACTIVE PARTICLES | UNIVERSITY OF STRATHCLYDE (GB) | 2004-01-22 | — | — | WO | claimed |
| WO-2003101580-A1 | SOLID MYCOCTOXIN CARRIERS | Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung (AT) | 2003-12-11 | — | — | WO | claimed |
| US-4678819-A | CASTING POLYMERIZATION | MITSUBISHI RAYON CO., LTD. (JP) | 1987-07-07 | — | — | US | claimed |
| US-4612325-A | 5-Aroyl-6-alkylthio-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1-carboxylic acids and use thereof as analgesics and anti-inflammatories | SYNTEX (U.S.A) INC. (US) | 1986-09-16 | — | — | US | claimed |
| EP-0096583-A2 | 5-Aroyl-1,2-dihydro-3H-pyrrolo 1,2-a pyrrole-1-carboxylic acids and derivatives thereof, processes for their preparation, and intermediates therefor | SYNTEX (U.S.A.) INC. (US) | 1983-12-21 | — | — | EP | claimed |
| US-4011201-A | POLYMERS OF MONOMERS CONTAINING ACTIVE METHYLENE GROUPS AND OTHER ETHYLENICALLY UNSATURATED MONOMERS | EASTMAN KODAK COMPANY (US) | 1977-03-08 | — | — | US | claimed |
| US-3939130-A | Polymers of monomers containing active methylene groups and other ethylenically unsaturated monomers | INDICON INC. (US) | 1976-02-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | THRB 3872/4885CA2 2722/4885TSHR 4448/4885 |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | THRB 3872/4885CA2 2722/4885TSHR 4448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.